United States · 
Who invested in Hillhurst Biopharmaceuticals?
Hillhurst Biopharmaceuticals's investors include National Institutes of Health and National Heart, Lung and Blood Institute.
United States · Funded startup
Who invested in Hillhurst Biopharmaceuticals
Funding summaryUpdated 26 Oct 2026
$6.3Mraised across 1 round since 2025, from 1 source
- Latest round
- Grant, $6.3MMay 2025
- Investors
- 2
The rounds
- May 2025
Founders and team
From the SEC filings it signed: 2 on the team.
- Andrew GompertsExecutive Officer, Directori
- Edward GompertsExecutive Officer, Directori
On the board, as filediJeff Friedman
Everyone who backed them
National Heart, Lung and Blood InstituteVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Hillhurst Biopharmaceuticals
How much has Hillhurst Biopharmaceuticals raised?
Hillhurst Biopharmaceuticals has raised $6.3M across 1 round since 2025.
When did Hillhurst Biopharmaceuticals last raise?
Hillhurst Biopharmaceuticals's most recent round was a Grant of $6.3M in May 2025.
What was Hillhurst Biopharmaceuticals's biggest round?
Its most recent round, $6.3M in May 2025, is also its largest on record.
Who backed Hillhurst Biopharmaceuticals first?
Hillhurst Biopharmaceuticals's first round on record, in May 2025, was backed by National Institutes of Health and National Heart, Lung and Blood Institute.
What stage is Hillhurst Biopharmaceuticals at?
Hillhurst Biopharmaceuticals's latest named round is a Grant, in May 2025.
Where is Hillhurst Biopharmaceuticals based?
Hillhurst Biopharmaceuticals is based in the United States.
Companies like Hillhurst Biopharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.